EDELWEISS MSCI INDIA DOMESTIC & WORLD HEALTHCARE 45 INDEX vs Mirae Asset Nifty 500 Healthcare ETF
Edelweiss vs Mirae· Portfolio Overlap Analysis
67.9%High Overlap
25 common stocksRank #3405 / 5,000
Investor takeaway: These funds overlap 67.9%. Holding both gives you almost no extra diversification. You are effectively paying two expense ratios for the same portfolio core.
Common Holdings (25)
| Stock | Wt% in EDELWEISS MSCI INDIA DOMESTIC | Wt% in Mirae Asset Nifty 500 Healthca | Overlap |
|---|---|---|---|
Sun Pharmaceutical Industries Ltd. Pharmaceuticals & Biotechnology | 11.25% | 10.02% | 10.02% |
Max Healthcare Institute Ltd. Healthcare Services | 5.73% | 6.78% | 5.73% |
Apollo Hospitals Enterprise Ltd. Healthcare Services | 5.69% | 6.72% | 5.69% |
Divi's Laboratories Ltd. Pharmaceuticals & Biotechnology | 5.17% | 6.80% | 5.17% |
Cipla Ltd. Pharmaceuticals & Biotechnology | 5.14% | 6.33% | 5.14% |
Dr. Reddy's Laboratories Ltd. Pharmaceuticals & Biotechnology | 4.71% | 6.54% | 4.71% |
Lupin Ltd. Pharmaceuticals & Biotechnology | 3.90% | 4.66% | 3.90% |
Torrent Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology | 3.46% | 3.78% | 3.46% |
Fortis Healthcare Ltd. Healthcare Services | 3.12% | 4.10% | 3.12% |
Laurus Labs Ltd. Pharmaceuticals & Biotechnology | 2.55% | 3.49% | 2.55% |
Glenmark Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology | 2.24% | 2.69% | 2.24% |
Aurobindo Pharma Ltd. Pharmaceuticals & Biotechnology | 2.15% | 2.85% | 2.15% |
Mankind Pharma Ltd. Pharmaceuticals & Biotechnology | 1.88% | 2.12% | 1.88% |
Alkem Laboratories Ltd. Pharmaceuticals & Biotechnology | 1.82% | 2.75% | 1.82% |
IPCA Laboratories Ltd. Pharmaceuticals & Biotechnology | 1.44% | 1.77% | 1.44% |
Biocon Ltd. Pharmaceuticals & Biotechnology | 1.41% | 2.32% | 1.41% |
Zydus Lifesciences Ltd. Pharmaceuticals & Biotechnology | 1.25% | 1.93% | 1.25% |
Aster DM Healthcare Ltd. Healthcare Services | 1.03% | 1.27% | 1.03% |
Gland Pharma Ltd. Pharmaceuticals & Biotechnology | 0.91% | 1.21% | 0.91% |
Narayana Hrudayalaya ltd. Healthcare Services | 0.88% | 1.04% | 0.88% |
Ajanta Pharma Ltd. Pharmaceuticals & Biotechnology | 0.88% | 1.05% | 0.88% |
GlaxoSmithKline Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology | 0.73% | 0.89% | 0.73% |
Piramal Pharma Ltd. Pharmaceuticals & Biotechnology | 0.63% | 0.81% | 0.63% |
Global Health Ltd. Healthcare Services | 0.62% | 0.80% | 0.62% |
Syngene International Ltd. Healthcare Services | 0.52% | 0.67% | 0.52% |
Unique to EDELWEISS MSCI INDIA DOMESTIC
All top holdings are shared with the other fund.
Unique to Mirae Asset Nifty 500 Healthca
All top holdings are shared with the other fund.
Sector Overlap Breakdown
Pharmaceuticals & Biotechnology50.3% (18)
Healthcare Services17.6% (7)
More comparisons for EDELWEISS MSCI INDIA DOMESTIC
- vs Motilal Oswal BSE Healthcare E69.0% · 25 stocks
- vs ADITYA BIRLA SUN LIFE NIFTY HE64.1% · 19 stocks
- vs Axis NIFTY Healthcare ETF64.1% · 19 stocks
- vs DSP Nifty Healthcare ETF64.1% · 19 stocks
- vs ICICI Prudential Nifty Healthc64.1% · 19 stocks
More comparisons for Mirae Asset Nifty 500 Healthca
- vs Motilal Oswal BSE Healthcare E88.9% · 50 stocks
- vs ADITYA BIRLA SUN LIFE NIFTY HE78.3% · 20 stocks
- vs Axis NIFTY Healthcare ETF78.3% · 20 stocks
- vs DSP Nifty Healthcare ETF78.3% · 20 stocks
- vs ICICI Prudential Nifty Healthc78.3% · 20 stocks
Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.